Bank of America’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $98.7M | Buy |
1,409,679
+423,319
| +43% | +$21.9M | 0.01% | 1203 |
|
|
2026
Q1 | $50.1M | Sell |
986,360
-388,494
| -28% | -$18.1M | ﹤0.01% | 1592 |
|
|
2025
Q4 | $40.5M | Sell |
1,374,854
-272,217
| -17% | -$7.4M | ﹤0.01% | 1702 |
|
|
2025
Q3 | $42.5M | Sell |
1,647,071
-132,238
| -7% | -$3.69M | ﹤0.01% | 1891 |
|
|
2025
Q2 | $49.1M | Buy |
1,779,309
+813,974
| +84% | +$21.4M | ﹤0.01% | 1724 |
|
|
2025
Q1 | $27.4M | Buy |
965,335
+219,474
| +29% | +$7.79M | ﹤0.01% | 2134 |
|
|
2024
Q4 | $31M | Sell |
745,861
-322,412
| -30% | -$15.4M | ﹤0.01% | 1890 |
|
|
2024
Q3 | $71.4M | Buy |
1,068,273
+80,423
| +8% | +$7.38M | 0.01% | 1291 |
|
|
2024
Q2 | $117M | Buy |
987,850
+70,015
| +8% | +$8.86M | 0.01% | 931 |
|
|
2024
Q1 | $97.8M | Buy |
917,835
+159,736
| +21% | +$16.1M | 0.01% | 1031 |
|
|
2023
Q4 | $75.4M | Sell |
758,099
-256,364
| -25% | -$21.6M | 0.01% | 1104 |
|
|
2023
Q3 | $105M | Buy |
1,014,463
+227,538
| +29% | +$25.4M | 0.01% | 859 |
|
|
2023
Q2 | $95.6M | Sell |
786,925
-172,372
| -18% | -$23M | 0.01% | 919 |
|
|
2023
Q1 | $147M | Buy |
959,297
+373,563
| +64% | +$61.6M | 0.02% | 748 |
|
|
2022
Q4 | $105M | Sell |
585,734
-472,334
| -45% | -$77.2M | 0.01% | 862 |
|
|
2022
Q3 | $125M | Buy |
1,058,068
+219,132
| +26% | +$33.3M | 0.02% | 757 |
|
|
2022
Q2 | $120M | Sell |
838,936
-574,391
| -41% | -$82.1M | 0.01% | 798 |
|
|
2022
Q1 | $243M | Buy |
1,413,327
+262,249
| +23% | +$44.2M | 0.02% | 572 |
|
|
2021
Q4 | $292M | Buy |
1,151,078
+352,026
| +44% | +$103M | 0.03% | 516 |
|
|
2021
Q3 | $308M | Buy |
799,052
+108,519
| +16% | +$40M | 0.03% | 482 |
|
|
2021
Q2 | $162M | Sell |
690,533
-235,926
| -25% | -$42.2M | 0.02% | 725 |
|
|
2021
Q1 | $121M | Sell |
926,459
-261,441
| -22% | -$37.9M | 0.01% | 796 |
|
|
2020
Q4 | $124M | Buy |
1,187,900
+563,811
| +90% | +$57M | 0.02% | 695 |
|
|
2020
Q3 | $44.2M | Sell |
624,089
-12,981
| -2% | -$905K | 0.01% | 1151 |
|
|
2020
Q2 | $40.9M | Buy |
637,070
+236,414
| +59% | +$12.9M | 0.01% | 1131 |
|
|
2020
Q1 | $12M | Buy |
400,656
+47,172
| +13% | +$1.09M | ﹤0.01% | 1905 |
|
|
2019
Q4 | $6.91M | Buy |
353,484
+133,684
| +61% | +$2.37M | ﹤0.01% | 2927 |
|
|
2019
Q3 | $3.5M | Sell |
219,800
-40,644
| -16% | -$600K | ﹤0.01% | 3547 |
|
|
2019
Q2 | $3.81M | Buy |
260,444
+151,275
| +139% | +$3.25M | ﹤0.01% | 3491 |
|
|
2019
Q1 | $2.22M | Buy |
109,169
+69,161
| +173% | +$1.28M | ﹤0.01% | 3899 |
|
|
2018
Q4 | $611K | Buy |
+40,008
| New | +$657K | ﹤0.01% | 4796 |
|
Other funds holding MRNA
TP
Bank of America's MRNA Position: Q2 2026 in Review
Bank of America increased its Moderna (MRNA) stake by 43% in Q2 2026, buying an estimated $21.9M and bringing the position to 1,409,679 shares worth $98.7M. The position accounts for 0.01% of the portfolio, ranked #1203.
Bank of America first reported a position in MRNA in Q4 2018 and has held it in 31 quarters since. The position peaked at $308M in Q3 2021. 775 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- Bank of America held 1,409,679 shares of Moderna worth $98.7M as of Q2 2026.
- Bank of America bought 423,319 Moderna shares in Q2 2026, an estimated $21.9M.
- Moderna made up 0.01% of Bank of America's portfolio in Q2 2026, its #1203 holding.
- Bank of America first reported a position in Moderna in Q4 2018 and has held it in 31 quarters since.
- Bank of America's Moderna position peaked at $308M in Q3 2021.
- 775 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.